{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:02:07Z","timestamp":1755799327302,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305562\/2020-7"],"award-info":[{"award-number":["305562\/2020-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study performs a chemical investigation of blood plasma samples from patients with and without fibromyalgia, combined with some of the symptoms and their levels of intensity used in the diagnosis of this disease. The symptoms evaluated were: visual analogue pain scale (VAS); fibromyalgia impact questionnaire (FIQ); Hamilton anxiety rating scale (HAM); Tampa Scale for Kinesiophobia (TAMPA); quality of life Questionnaire\u2014physical and mental health (QL); and Pain Catastrophizing Scale (CAT). Plasma samples were analyzed by paper spray ionization mass spectrometry (PSI-MS). Spectral data were organized into datasets and related to each of the symptoms measured. The datasets were submitted to multivariate classification using supervised models such as principal component analysis with linear discriminant analysis (PCA-LDA), successive projections algorithm with linear discriminant analysis (SPA-LDA), genetic algorithm with linear discriminant analysis (GA-LDA) and their versions with quadratic discriminant analysis (PCA\/SPA\/GA-QDA) and support vector machines (PCA\/SPA\/GA-SVM). These algorithm combinations were performed aiming the best class separation. Good discrimination between the controls and fibromyalgia samples were observed using PCA-LDA, where the spectral data associated with the CAT symptom achieved 100% classification sensitivity, and associated with the VAS symptom achieved 100% classification specificity, with both symptoms at the moderate level of intensity. The spectral variable at 579\u00a0<jats:italic>m\/z<\/jats:italic> was found to be substantially significant for classification according to the PCA loadings. According to the human metabolites database, this variable can be associated with a LysoPC compound, which comprises a class of metabolites already evidenced in other studies for fibromyalgia diagnosis. This study proposed an investigation of spectral data combined with clinical data to compare the classification ability of different datasets. The good classification results obtained confirm this technique is as a good analytical tool for the detection of fibromyalgia, and provides theoretical support for other studies about fibromyalgia diagnosis.<\/jats:p>","DOI":"10.1038\/s41598-023-31565-0","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:14:42Z","timestamp":1679861682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Spectrochemical approach combined with symptoms data to diagnose fibromyalgia through paper spray ionization mass spectrometry (PSI-MS) and multivariate classification"],"prefix":"10.1038","volume":"13","author":[{"given":"Marcelo V. S.","family":"Alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanaia I. L.","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o O. S.","family":"Passos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo L. M.","family":"Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marfran C. D.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leomir A. S.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boniek G.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Pegado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e1ssio M. G.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"31565_CR1","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"DJ Clauw","year":"2014","unstructured":"Clauw, D. J. Fibromyalgia: A clinical review. J. Am. Med. Assoc. 311, 1547\u20131555 (2014).","journal-title":"J. Am. Med. Assoc."},{"key":"31565_CR2","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.mayocp.2015.03.014","volume":"90","author":"DJ Clauw","year":"2015","unstructured":"Clauw, D. J. Fibromyalgia and related conditions. Mayo Clin. Proc. 90, 680\u2013692 (2015).","journal-title":"Mayo Clin. Proc."},{"key":"31565_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-384978-6.00090-X","author":"MB Yunus","year":"2013","unstructured":"Yunus, M. B. Fibromyalgia: A central sensitivity syndrome. Women Health. https:\/\/doi.org\/10.1016\/B978-0-12-384978-6.00090-X (2013).","journal-title":"Women Health."},{"key":"31565_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe, F. et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 33, 160\u2013172 (1990).","journal-title":"Arthritis Rheum."},{"key":"31565_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1515\/sjpain-2020-0072","volume":"20","author":"F Wolfe","year":"2020","unstructured":"Wolfe, F. The history of the idea of widespread pain and its relation to fibromyalgia. Scand. J. Pain 20, 647\u2013650 (2020).","journal-title":"Scand. J. Pain"},{"key":"31565_CR6","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe, F. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. (Hoboken) 62, 600\u2013610 (2010).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"31565_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe, F. et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia. J. Rheumatol. 38, 1113\u20131122 (2011).","journal-title":"J. Rheumatol."},{"key":"31565_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe, F. et al. 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 46, 319\u2013329 (2016).","journal-title":"Semin. Arthritis Rheum."},{"key":"31565_CR9","first-page":"3","volume":"35","author":"F Wolfe","year":"2017","unstructured":"Wolfe, F. Criteria for fibromyalgia? What is fibromyalgia? Limitations to current concepts of fibromyalgia and fibromyalgia criteria. Clin. Exp. Rheumatol. 35, 3\u20135 (2017).","journal-title":"Clin. Exp. Rheumatol."},{"key":"31565_CR10","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s40744-021-00318-8","volume":"8","author":"JH Kang","year":"2021","unstructured":"Kang, J. H. et al. Comparison of the AAPT fibromyalgia diagnostic criteria and modified FAS criteria with existing ACR criteria for fibromyalgia in Korean patients. Rheumatol. Ther. 8, 1003\u20131014 (2021).","journal-title":"Rheumatol. Ther."},{"key":"31565_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1472-6963-10-102","volume":"10","author":"E Choy","year":"2010","unstructured":"Choy, E. et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv. Res. 10, 102 (2010).","journal-title":"BMC Health Serv. Res."},{"key":"31565_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/art.21545","volume":"54","author":"G Hughes","year":"2006","unstructured":"Hughes, G., Martinez, C., Myon, E., Ta\u00efeb, C. & Wessely, S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: An observational study based on clinical practice. Arthritis Rheum. 54, 177\u2013183 (2006).","journal-title":"Arthritis Rheum."},{"key":"31565_CR13","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/prca.200900076","volume":"3","author":"L Bazzichi","year":"2009","unstructured":"Bazzichi, L. et al. Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteom. Clin. Appl. 3, 1296\u20131304 (2009).","journal-title":"Proteom. Clin. Appl."},{"key":"31565_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11306-019-1513-6","volume":"15","author":"BG Malatji","year":"2019","unstructured":"Malatji, B. G. et al. The GC\u2013MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology. Metabolomics 15, 54 (2019).","journal-title":"Metabolomics"},{"key":"31565_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/cts.12679","volume":"13","author":"V Menzies","year":"2020","unstructured":"Menzies, V. et al. Metabolomic differentials in women with and without fibromyalgia. Clin. Transl. Sci. 13, 67\u201377 (2020).","journal-title":"Clin. Transl. Sci."},{"key":"31565_CR16","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1074\/jbc.RA118.005816","volume":"294","author":"KV Hackshaw","year":"2019","unstructured":"Hackshaw, K. V. et al. Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders. J. Biol. Chem. 294, 2555\u20132568 (2019).","journal-title":"J. Biol. Chem."},{"key":"31565_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-68781-x","volume":"10","author":"JOS Passos","year":"2020","unstructured":"Passos, J. O. S. et al. Spectrochemical analysis in blood plasma combined with subsequent chemometrics for fibromyalgia detection. Sci. Rep. 10, 1\u20138 (2020).","journal-title":"Sci. Rep."},{"key":"31565_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-02141-1","volume":"11","author":"MVS Alves","year":"2021","unstructured":"Alves, M. V. S. et al. Multivariate classification techniques and mass spectrometry as a tool in the screening of patients with fibromyalgia. Sci. Rep. 11, 1 (2021).","journal-title":"Sci. Rep."},{"key":"31565_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1373\/clinchem.2015.248146","volume":"62","author":"PJ Jannetto","year":"2016","unstructured":"Jannetto, P. J. & Fitzgerald, R. L. Effective use of mass spectrometry in the clinical laboratory. Clin. Chem. 62, 92\u201398 (2016).","journal-title":"Clin. Chem."},{"key":"31565_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/14789450.2021.1893695","volume":"18","author":"OP Trifonova","year":"2021","unstructured":"Trifonova, O. P., Maslov, D. L., Balashova, E. E. & Lokhov, P. G. Mass spectrometry-based metabolomics diagnostics\u2013myth or reality? Expert Rev. Proteom. 18, 7\u201312 (2021).","journal-title":"Expert Rev. Proteom."},{"key":"31565_CR21","doi-asserted-by":"publisher","first-page":"e4584","DOI":"10.1002\/jms.4584","volume":"55","author":"A Bhatnagar","year":"2020","unstructured":"Bhatnagar, A. et al. Evaluating bioanalytical capabilities of paper spray ionization for abiraterone drug quantification in patient plasma. J. Mass Spectrom. 55, e4584 (2020).","journal-title":"J. Mass Spectrom."},{"key":"31565_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1039\/C005327A","volume":"149","author":"RG Cooks","year":"2011","unstructured":"Cooks, R. G. et al. New ionization methods and miniature mass spectrometers for biomedicine: DESI imaging for cancer diagnostics and paper spray ionization for therapeutic drug monitoring. Faraday Discuss. 149, 247\u2013267 (2011).","journal-title":"Faraday Discuss."},{"key":"31565_CR23","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1021\/acs.analchem.9b03966","volume":"92","author":"YC Huang","year":"2020","unstructured":"Huang, Y. C. et al. Predicting breast cancer by paper spray ion mobility spectrometry mass spectrometry and machine learning. Anal. Chem. 92, 1653\u20131657 (2020).","journal-title":"Anal. Chem."},{"key":"31565_CR24","doi-asserted-by":"publisher","first-page":"104548","DOI":"10.1016\/j.chemolab.2022.104548","volume":"224","author":"A Ghosh","year":"2022","unstructured":"Ghosh, A. et al. Deep reinforced neural network model for cyto-spectroscopic analysis of epigenetic markers for automated oral cancer risk prediction. Chemom. Intell. Lab. Syst. 224, 104548 (2022).","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"31565_CR25","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1039\/c6an01247g","volume":"141","author":"LFS Siqueira","year":"2016","unstructured":"Siqueira, L. F. S. & Lima, K. M. G. MIR-biospectroscopy coupled with chemometrics Chemometrics in MIR. The Analyst 141, 4833\u20134847. https:\/\/doi.org\/10.1039\/c6an01247g (2016).","journal-title":"The Analyst"},{"key":"31565_CR26","first-page":"472","volume":"29","author":"CL Morais","year":"2018","unstructured":"Morais, C. L. & Lima, K. M. Principal component analysis with linear and quadratic discriminant analysis for identification of cancer samples based on mass spectrometry. J. Braz. Chem. Soc. 29, 472\u2013481 (2018).","journal-title":"J. Braz. Chem. Soc."},{"key":"31565_CR27","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1021\/ac034173t","volume":"75","author":"PHC Eilers","year":"2003","unstructured":"Eilers, P. H. C. A perfect smoother. Anal. Chem. 75, 3631\u20133636 (2003).","journal-title":"Anal. Chem."},{"key":"31565_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12859-019-2848-8","volume":"20","author":"E Gorrochategui","year":"2019","unstructured":"Gorrochategui, E., Jaumot, J. & Tauler, R. ROIMCR: A powerful analysis strategy for LC-MS metabolomic datasets. BMC Bioinform. 20, 8 (2019).","journal-title":"BMC Bioinform."},{"key":"31565_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/nar\/gkl923","volume":"35","author":"DS Wishart","year":"2007","unstructured":"Wishart, D. S. et al. HMDB: The human metabolome database. Nucleic Acids Res. 35, 521\u2013526 (2007).","journal-title":"Nucleic Acids Res."},{"key":"31565_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/nar\/gkl838","volume":"35","author":"M Sud","year":"2007","unstructured":"Sud, M. et al. LMSD: LIPID MAPS structure database. Nucleic Acids Res. 35, 527\u2013533 (2007).","journal-title":"Nucleic Acids Res."},{"key":"31565_CR31","doi-asserted-by":"publisher","first-page":"e107626","DOI":"10.1371\/journal.pone.0107626","volume":"9","author":"P Caboni","year":"2014","unstructured":"Caboni, P. et al. Metabolomics analysis and modeling suggest a lysophosphocholines-PAF receptor interaction in fibromyalgia. PLoS ONE 9, e107626 (2014).","journal-title":"PLoS ONE"},{"key":"31565_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3166\/dea-2021-0169","volume":"34","author":"A Delage","year":"2021","unstructured":"Delage, A. Lysophosphatidylcholine 16:0, a promising biomarker for severe fibromyalgia. Douleur et Anal. 34, 195\u2013198 (2021).","journal-title":"Douleur et Anal."},{"key":"31565_CR33","first-page":"1","volume":"00","author":"K Hackshaw","year":"2020","unstructured":"Hackshaw, K. & Hackshaw, K. Expert review of molecular diagnostics assessing our approach to diagnosing fibromyalgia assessing our approach to diagnosing fibromyalgia article history. Expert Rev. Mol. Diagn. 00, 1\u201311 (2020).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"31565_CR34","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1134\/S106193482108013X","volume":"76","author":"EI Savelieva","year":"2021","unstructured":"Savelieva, E. I. Scopes of bioanalytical chromatography\u2013mass spectrometry. J. Anal. Chem. 76, 1198\u20131210 (2021).","journal-title":"J. Anal. Chem."},{"key":"31565_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/05704928.2019.1694937","volume":"56","author":"CAM Ramirez","year":"2021","unstructured":"Ramirez, C. A. M., Greenop, M. & Ashton, L. Applications of machine learning in spectroscopy. Appl. Spectrosc. Rev. 56, 1\u201331 (2021).","journal-title":"Appl. Spectrosc. Rev."},{"key":"31565_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/diagnostics11020156","volume":"11","author":"KV Hackshaw","year":"2021","unstructured":"Hackshaw, K. V. The search for biomarkers in fibromyalgia. Diagnostics 11, 156 (2021).","journal-title":"Diagnostics"},{"key":"31565_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2020.03.028","author":"S Hallit","year":"2020","unstructured":"Hallit, S. et al. Validation of the Hamilton anxiety rating scale and state trait anxiety inventory A and B in Arabic among the Lebanese population. Clin. Epidemiol. Glob. Health. https:\/\/doi.org\/10.1016\/j.cegh.2020.03.028 (2020).","journal-title":"Clin. Epidemiol. Glob. Health."},{"key":"31565_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/metabo11070429","volume":"11","author":"C Marino","year":"2021","unstructured":"Marino, C. et al. Fibromyalgia and depression in women: An 1h-nmr metabolomic study. Metabolites 11, 429 (2021).","journal-title":"Metabolites"},{"key":"31565_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/mpr.323","volume":"19","author":"LS Matza","year":"2010","unstructured":"Matza, L. S., Morlock, R., Sexton, C., Malley, K. & Feltner, D. Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder. Int. J. Methods Psychiatr. Res. 19, 223\u2013232 (2010).","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"31565_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bjpt.2020.05.004","volume":"25","author":"EMES Salvador","year":"2021","unstructured":"Salvador, E. M. E. S., Franco, K. F. M., Miyamoto, G. C., dos Franco, Y. R. S. & Cabral, C. M. N. Analysis of the measurement properties of the Brazilian-Portuguese version of the Tampa Scale for Kinesiophobia-11 in patients with fibromyalgia. Braz. J. Phys. Ther. 25, 168\u2013174 (2021).","journal-title":"Braz. J. Phys. Ther."},{"key":"31565_CR41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.rbr.2015.09.009","volume":"56","author":"TO Trocoli","year":"2016","unstructured":"Trocoli, T. O. & Botelho, R. V. Preval\u00eancia de ansiedade, depress\u00e3o e cinesiofobia em pacientes com lombalgia e sua associa\u00e7\u00e3o com os sintomas da lombalgia. Rev. Bras. Reumatol. 56, 330\u2013336 (2016).","journal-title":"Rev. Bras. Reumatol."},{"key":"31565_CR42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1590\/S1517-86922012000500005","volume":"18","author":"L Roman Pedro \u00c1ngel","year":"2012","unstructured":"Roman Pedro \u00c1ngel, L., Aparecida Santos Campos, M., Armando Mej\u00eda Meza, J., Delgado Fern\u00e1ndez, M. & Mar\u00eda Heredia, J. An\u00e1lise das capacidades f\u00edsicas de mulheres com fibromialgia segundo o n\u00edvel de gravidade da enfermidade analysis of the physical capacity of women with fibromyalgia according to the severity level of the disease artigo original cl\u00ednica m\u00e9dica do exerc\u00edcio e do esporte resumo. Rev. Bras. Med. Esporte 18, 308 (2012).","journal-title":"Rev. Bras. Med. Esporte"},{"key":"31565_CR43","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.mayocp.2013.09.021","volume":"89","author":"J Jiao","year":"2014","unstructured":"Jiao, J., Vincent, A., Cha, S. S., Luedtke, C. A. & Oh, T. H. Relation of age with symptom severity and quality of life in patients with fibromyalgia. Mayo Clin. Proc. 89, 199\u2013206 (2014).","journal-title":"Mayo Clin. Proc."},{"key":"31565_CR44","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3899\/jrheum.081090","volume":"36","author":"RM Bennett","year":"2009","unstructured":"Bennett, R. M., Bushmakin, A. G., Cappelleri, J. C., Zlateva, G. & Sadosky, A. B. Minimal clinically important difference in the fibromyalgia impact questionnaire. J. Rheumatol. 36, 1304\u20131311 (2009).","journal-title":"J. Rheumatol."},{"key":"31565_CR45","first-page":"1","volume":"161","author":"GM Trovato","year":"2010","unstructured":"Trovato, G. M. et al. PAIN VAS and illness perception. Rheumatol. Clin. Ther. 161, 1 (2010).","journal-title":"Rheumatol. Clin. Ther."},{"key":"31565_CR46","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1016\/j.pain.2014.09.014","volume":"155","author":"AM Boonstra","year":"2014","unstructured":"Boonstra, A. M., Preuper, H. R. S., Balk, G. A. & Stewart, R. E. Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain. Pain 155, 2545\u20132550 (2014).","journal-title":"Pain"},{"key":"31565_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1526-5900(03)00716-8","volume":"4","author":"MP Jensen","year":"2003","unstructured":"Jensen, M. P., Chen, C. & Brugger, A. M. Interpretation of visual analog scale ratings and change scores: A reanalysis of two clinical trials of postoperative pain. J. Pain 4, 407\u2013414 (2003).","journal-title":"J. Pain"},{"key":"31565_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph19074198","volume":"19","author":"L Sanrom\u00e1n","year":"2022","unstructured":"Sanrom\u00e1n, L. et al. The role of walking in the relationship between catastrophizing and fatigue in women with fibromyalgia. Int. J. Environ. Res. Public Health 19, 1 (2022).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"31565_CR49","unstructured":"Morais, C. L. M. Universidade Federal Do Rio Grande do Norte Instituto de Qu\u00edmica Programa de P\u00f3s-gradua\u00e7\u00e3o em Qu\u00edmica Development of Supervised Classification Techniques for Multivariate Chemical Data Camilo de Lelis Medeiros de Morais (2017)."},{"key":"31565_CR50","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0165-9936(91)85132-B","volume":"10","author":"CB Lucasius","year":"1991","unstructured":"Lucasius, C. B. & Kateman, G. Genetic algorithms for large-scale optimization in chemometrics: An application. TrAC Trends Anal. Chem. 10, 254\u2013261 (1991).","journal-title":"TrAC Trends Anal. Chem."},{"key":"31565_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.chemolab.2017.01.021","volume":"162","author":"LFS Siqueira","year":"2017","unstructured":"Siqueira, L. F. S., Ara\u00fajo J\u00fanior, R. F., de Ara\u00fajo, A. A., Morais, C. L. M. & Lima, K. M. G. LDA vs. QDA for FT-MIR prostate cancer tissue classification. Chemom. Intell. Lab. Syst. 162, 123\u2013129 (2017).","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"31565_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cem.3075","volume":"32","author":"LFS Siqueira","year":"2018","unstructured":"Siqueira, L. F. S., Morais, C. L. M., Ara\u00fajo J\u00fanior, R. F., de Ara\u00fajo, A. A. & Lima, K. M. G. SVM for FT-MIR prostate cancer classification: An alternative to the traditional methods. J. Chemom. 32, 1\u201319 (2018).","journal-title":"J. Chemom."},{"key":"31565_CR53","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1039\/C7AY00428A","volume":"9","author":"CLM Morais","year":"2017","unstructured":"Morais, C. L. M., Costa, F. S. L. & Lima, K. M. G. Variable selection with a support vector machine for discriminating: Cryptococcus fungal species based on ATR-FTIR spectroscopy. Anal. Methods 9, 2964\u20132970 (2017).","journal-title":"Anal. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31565-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31565-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31565-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:16:27Z","timestamp":1679861787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31565-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["31565"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-31565-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"18 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4658"}}